Could a Vitamin B5 Derivative Help Relieve Psoriasis Symptoms?

A vitamin B5 derivative called pantethine could offer new hope for people living with psoriasis, an inflammatory skin condition that can cause persistent itching, soreness and scaly patches. Early research suggests the supplement may help reduce inflammation, potentially opening the door to new treatment options in the future.

Scientists investigating the effects of pantethine found promising results in animal experiments. A small human study also reported improvements among patients who took the supplement alongside conventional topical treatments. However, researchers have emphasised that further studies are necessary before pantethine can be recommended as an established treatment for psoriasis.

Understanding Psoriasis and Its Symptoms

Psoriasis is a long-term inflammatory condition that affects the skin. It develops when the immune system becomes overactive, causing skin cells to build up more quickly than usual. This can result in raised, dry patches covered with silvery scales, commonly known as plaques.

These patches may appear on the scalp, elbows, knees, hands, feet and other areas of the body. In some cases, psoriasis can affect sensitive areas and cause considerable discomfort.

Symptoms vary between individuals. Some people experience mild irritation, while others develop widespread inflammation, painful cracks in the skin and persistent itching. The condition can also affect sleep, emotional wellbeing and confidence.

Certain people with psoriasis develop psoriatic arthritis, an inflammatory condition that causes joint pain, stiffness and swelling.

Although several treatments are available to manage symptoms, there is currently no permanent cure for psoriasis. Treatment options include medicated creams, ointments, light therapy and medicines that influence immune system activity.

Researchers continue to investigate the biological processes behind the condition to identify additional ways of controlling inflammation.

What Is Pantethine?

Pantethine is a compound derived from vitamin B5, also known as pantothenic acid. Vitamin B5 helps the body carry out essential functions, including converting food into energy and supporting the production of certain important substances.

Pantethine is available as a dietary supplement and has also been investigated for its potential effects on cholesterol levels.

Scientists are now exploring whether it could have another important role in regulating immune activity and reducing inflammation.

The latest research examined how pantethine interacts with immune cells involved in the development of psoriasis. The findings suggest that the compound may help regulate processes associated with excessive inflammation.

However, evidence of a potential benefit does not mean that taking pantethine supplements will prevent psoriasis or reliably improve symptoms in people.

How Could Pantethine Influence Inflammation?

The research focused on specialised immune cells called dendritic cells. These cells help coordinate immune responses by recognising foreign substances and communicating with other parts of the immune system.

Although dendritic cells play an essential role in protecting the body, inappropriate activation can contribute to inflammatory and autoimmune conditions.

Researchers identified a possible connection between enzymes known as Vanins, cholesterol production and the activity of these immune cells.

According to the study, increased Vanin activity can reduce pantethine levels within dendritic cells. This may contribute to excessive cholesterol production, encouraging the cells to become overactive and promote inflammation.

The researchers investigated whether restoring pantethine levels could help interrupt this process.

Their findings suggested that adding pantethine helped limit excessive cholesterol accumulation and reduced the activation of dendritic cells.

This is significant because understanding how immune cells become overactive could help scientists identify new approaches to managing inflammatory diseases.

Nevertheless, the precise biological mechanisms and their importance in human psoriasis require further investigation.

Promising Results From Animal Research

In experiments involving mice, researchers found that pantethine treatment helped prevent the development of psoriasis-like symptoms.

The findings suggested that the compound could influence biological pathways associated with inflammation and abnormal immune activity.

Animal studies are an important stage in medical research because they allow scientists to investigate how potential treatments work before conducting larger human trials.

However, results in animals do not always translate into similar benefits in people. Differences in biology, disease development, dosage and treatment response can influence whether an experimental approach proves effective in clinical practice.

Consequently, the results provide a starting point for further investigation rather than proof that pantethine can prevent psoriasis in humans.

What Did the Human Study Discover?

Alongside the animal experiments, researchers conducted a small study involving 24 people with psoriasis.

All participants received topical treatments commonly used to manage the condition. Half also received pantethine supplements, allowing the researchers to explore whether adding the compound could provide additional benefits.

Over a period of 12 weeks, the group receiving pantethine alongside their usual topical treatment experienced improvements in symptoms.

The researchers also reported that the benefits appeared particularly noticeable among participants who had elevated cholesterol levels at the beginning of the study.

These findings may help scientists understand whether cholesterol metabolism plays a role in certain cases of psoriasis and whether targeting related biological processes could improve treatment outcomes.

However, the study involved only a small number of participants. Larger clinical trials are needed to establish how effective pantethine may be, which patients might benefit most and whether the results can be consistently reproduced.

Further research is also necessary to assess potential side effects, suitable dosages and long-term safety.

Could Pantethine Become a New Psoriasis Treatment?

The results have generated interest because pantethine may influence some of the processes associated with psoriasis rather than simply addressing visible symptoms.

If future studies confirm these findings, the compound could potentially become an additional treatment option for selected patients.

Researchers are particularly interested in how metabolism, cholesterol and immune activity interact in inflammatory diseases. A better understanding of these relationships could contribute to the development of new therapies.

However, pantethine should not currently be viewed as a replacement for established psoriasis treatments.

People considering dietary supplements should remember that products marketed as nutritional supplements may not have the same level of evidence supporting their use as licensed medicines.

Availability without a prescription does not automatically mean that a supplement is effective or suitable for everyone. Supplements can also have side effects or interact with medicines.

Anyone considering pantethine for psoriasis should discuss it with a qualified healthcare professional before starting supplementation, particularly if they take medication or have an existing medical condition.

People should continue following their prescribed treatment plans unless their healthcare professional recommends a change.

What Happens Next?

The researchers have described their findings as encouraging but preliminary. Additional studies will be necessary to determine whether pantethine offers meaningful and sustained benefits for people living with psoriasis.

Future research should involve larger groups of participants, appropriate comparison groups and longer follow-up periods. These studies could help establish whether the supplement is effective, identify possible risks and determine which patients might benefit most.

Scientists will also need to investigate the biological mechanisms observed in the laboratory to establish how closely they reflect the processes occurring in people with psoriasis.

For now, the findings represent an early step towards understanding how a vitamin B5 derivative might influence immune activity and inflammation.

Although the results offer a promising research direction, more evidence is needed before pantethine can be considered a proven treatment for psoriasis.

Source: Cao, A.-P., Li, J.-C., Wang, R., et al. (2026). “Vanin-pantethine metabolic axis shapes dendritic cell function and affects inflammatory disorder progression.” Journal of Experimental Medicine, published 27 October 2026.

Medical disclaimer: This article is intended for general information and educational purposes only. It does not constitute medical advice, diagnosis or treatment recommendations. Pantethine has not been established as a proven treatment or cure for psoriasis. Consult a qualified healthcare professional before taking supplements or changing any prescribed medication.